Pages that link to "Q79967896"
Jump to navigation
Jump to search
The following pages link to Evidence of graft-versus-tumor effect in refractory metastatic neuroblastoma (Q79967896):
Displaying 11 items.
- 28 years of high-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 procedures (Q34785880) (← links)
- Reduced-Intensity Allogeneic Stem Cell Transplantation in Children and Young Adults with Ultrahigh-Risk Pediatric Sarcomas (Q35683306) (← links)
- I-131-Metaiodobenzylguanidine therapy with allogeneic cord blood stem cell transplantation for recurrent neuroblastoma. (Q36411942) (← links)
- Allogeneic or haploidentical HSCT for refractory or relapsed solid tumors in children: toward a neuroblastoma model (Q37315368) (← links)
- Engraftment of unrelated cord blood after reduced-intensity conditioning regimen in children with refractory neuroblastoma: a feasibility trial (Q39877306) (← links)
- Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients (Q40093716) (← links)
- Treatment of high-risk neuroblastoma (Q41761113) (← links)
- Reduced-intensity conditioning followed by allogeneic transplantation in pediatric malignancies: a report from the Société Française des Cancers de l'Enfant and the Société Française de Greffe de Moelle et de Thérapie Cellulaire. (Q46120530) (← links)
- Recent developments in cell-based immune therapy for neuroblastoma (Q80059433) (← links)
- Treatment and outcomes of patients with relapsed, high‐risk neuroblastoma: Results of German trials (Q83381330) (← links)
- Successful tandem (autologous-cord blood) SCT in advanced neuroblastomas with highly amplified MYCN (Q84707040) (← links)